Gianmarco Villano

机构：University of Padua · ORCID：0000-0001-5752-6626

发表论文 67 篇 · 总被引 613 次 · h-index 15

代表论文

• MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma (2019 · Journal of Clinical Medicine · 被引 48)
• SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets (2019 · Cancers · 被引 31)
• PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting (2019 · Materials Science and Engineering C · 被引 24)
• SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease (2022 · Frontiers in Immunology · 被引 22)
• Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation (2021 · Cellular and Molecular Gastroenterology and Hepatology · 被引 21)
• The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis (2024 · Molecular Metabolism · 被引 18)